PO Box 12878
6 Davis Drive, Suite 827
Boragen, established in 2017 in Research Triangle Park, is focused on leveraging the unique chemical properties of boron to develop novel synthetic chemistry platforms to produce next-generation fungicides that support more sustainable farming methods. The company’s lead compound decreases the probability of fungicide resistance and reduces the amount of chemical applied while maintaining performance and efficacy.
Founders: Stephen Benkovic, Gerald Fink, Paul Schimmel, Tony Liu and Lucy Shapiro
CEO: John W. Dombrosky
Founder and CSO: Tony Liu
5 articles with Boragen
It’s hard to believe 2018 is half over. There have been plenty of interesting and important stories in the biopharma space this year. Here’s a look at our top 10 stories so far, counting down from 10 to the number one story.
Think biotechnology, you probably think cutting-edge development of drugs to treat diseases. Yet in 2007, a U.S. EPA report noted that industrial biotechnology and biobased manufacturing are more efficient, cleaner and make better use of sustainable renewable resources.
1/10/2018Boragen is located in Research Triangle Park in Durham, N.C., and focuses on boron-based development of anti-bacterials and anti-fungicides for the agricultural industry.
BioSpace is proud to present its NextGen "Class of 2018," a list of 20 up-and-coming life science companies in North America that started up no earlier than 2015.
AgTech Accelerator Launches First Investment In Novel Fungicide Company, Boragen, With $10 Million Series A Financing